The London Clinic, a private hospital and charityon London’s Harley Street, has treated its first patient with Lutetium-177 PSMA therapy, a molecular radiotherapy treatment that targets and kills cancer cells precisely, minimising damage to healthy cells and tissue.

Lutetium-177 PSMA is used to treat advanced prostate cancer that has spread from the prostate to other parts of the body (also known as metastatic prostate cancer). The London Clinic’s specialists inject the medication into the patient’s bloodstream. It seeks out tumour cells and binds to them, delivering a high dose of radiation precisely to destroy cancer cells.

Resultsfrom a small number of clinical studies for Lutetium-177 PSMA therapy show that it reduces prostate specific antigen (PSA) in up to 70% of patients(Ref 1). The treatment has recently become available privately in the UK and The London Clinic is one of the leaders in offering it to patients whose disease has progressed after chemotherapy and who have received one of the new hormonal therapies (enzalutamide / abiraterone).

Professor Val Lewington, Nuclear Medicine Specialist at The London Clinic, says: “Lutetium-177 PSMA is an exciting development for men with prostate cancer that our team is proud to be able to deliver at The London Clinic.

Promising early clinical data for Lutetium-177 PSMA show that it is both effective and well tolerated, so we are optimistic that this new treatment will make a real difference to our patients and their families.”

Professor Adil Al-Nahhas, Nuclear Medicine Specialist at The London Clinic, says: “Lutetium-177 PSMA is an exciting innovative treatment for men with advanced prostate cancer when other treatments have failed.

In the clinical studies so far, it reduces PSA in many patients, improving their quality of life and giving them more time with their loved ones. We ask clinical oncologists to contact us if they have suitable patients that may benefit from this innovative treatment.”

Mr Satya Bhattacharya, Medical Director of The London Clinic, says: “The London Clinic is a pioneering hospital and we are proud to be in a position to offer this innovate prostate cancer treatment to our patients in the UK and from overseas.

“Our nuclear medicine, radiotherapy and medical physics teams are committed to excellent clinicaloutcomes for our patients and we are excited to see the progress of the patients we are treating.”

References and notes to editors 

1. Early initiation of Lu-177 PSMA radioligand therapy prolongs overall survival in metastatic prostate cancer, Kulkarnie et al, Bad Berka (Ref 1)
2. A global clinical trial involving UK NHS hospital is currently taking place. The London Clinic is not part of this but will be sharing clinical data about the patients it is treating.
3. The London Clinicis an independent, charitable hospital in Harley Street, the heart of London’s medical district. Our charitable status means that we reinvest our surplus income into the latest medical technologies for the overall benefit of people and the wider healthcare community.
   Our cutting-edge technology and internationally-renowned consultants attract thousands of UK and international patients every year. Our 600 consultants lead in specialties such as cancer care, digestive diseases, orthopaedics (including hips, knees, shoulders and fingers with on-site physiotherapy rehabilitation), neurology, digestive diseases, cosmetic surgery, liver services, gastroenterology, urology, endoscopy, diabetes, haematology and endocrinology.

CAR-T cell therapy is NICE approved. Patients from across the UK, Europe and international countries are set to benefit

The London Clinic, a private hospital and charity on London’s Harley Street, and is one of a small number of hospitals in the UK to offer adult patients with diffuse large B-cell lymphoma – an aggressive form of blood cancer – a new, cutting-edge form of immunotherapy called CAR-T cell therapy.

The CAR-T (chimeric antigen receptor T-cell) cell therapy works through the collection of immune cells (T cells) from the blood of patients. These T-cells are then genetically modified to destroy cancer cells in a laboratory and given back to the patient. This therapy is for patients who have no other treatment options having failed conventional chemotherapy.

A phase 2 clinical trial of 111 patients (https://www.ncbi.nlm.nih.gov/pubmed/29226797 ), has shown positive outcomes with 52% of patients treated with CAR-T therapy, living for 18 months after treatment. Real-world data is at an early stage but consistent with this positive outcome.

CAR-T therapy is approved by the UK’s National Institute for Health and Care Excellence (NICE). The London Clinic is HTA licensed and JACIE accredited and with access to a level 3 intensive care unit, patients who suffer any side-effects from the treatment can be cared for at one central hospital site..

Professor John Gribben, who is leading the treatment at The London Clinic, says: “CAR-T cell therapy is an exciting advancement in the treatment of blood cancers, offering a new, final treatment option for patients when others haven’t had the result they need from conventional therapy.

“Diffuse large B-cell lymphoma is an aggressive form of blood cancer. So far, this treatment is showing promising outcomes for many patients, letting them return to normal lives with their families and loved-ones. The London Clinic is a pioneering hospital and we are proud to be in a position to offer this treatment to our patients in the UK, Europe and from international countries,” adds Professor Gribben.

Mr Satya Bhattacharya, Medical Director of The London Clinic, says: “The London Clinic is committed to bringing together it’s strengths in clinical service, research, and innovation to successfully deliver new treatments such as CAR-T cell therapy and create positive outcomes for our patients.

“Our team of internationally-renowned haematologists and clinical nurses have specialist experience and expertise in all aspects of treating blood cancers and we are excited to be one of a small number of hospitals offering this exciting new treatment. Our charitable ethos means that we are committed to advancing healthcare knowledge across the wider community.”

CHAPPER healthcare – a leading UK based global specialist pharmaceutical wholesaler and distributor – is delighted to be exhibiting at The Clinical Pharmacy Congress in London to further develop its UK business.

Exhibiting for the first time, the CHAPPER healthcare team are eager to meet new and existing contacts interested in the supply of medicines to help address unmet patient needs.

Established in 1975, CHAPPER healthcare are specialists in the supply of medicines, including unlicensed ‘specials’ and unavailable or out of stock products. Their experienced team pride themselves on delivering exceptional customer service and supplying products safely, securely and on time to satisfy unmet patient need.

In the UK market and globally, CHAPPER healthcare is working in partnership with Oralieve to supply Oralieve® Dry Mouth Relief. The products have been specifically designed and tested with dry mouth sufferers to help supplement the natural protective enzyme system in saliva to provide effective and lasting relief for dry mouths.

Unlike many other products, Oralieve® Dry Mouth Relief products are powered by GALX technology – a unique combination of bioactive ingredients including enzymes, lactoperoxidase and glucose oxidase.

Jonathan Chapper, CEO of CHAPPER healthcare, said: “We are delighted to be exhibiting at The Clinical Pharmacy Congress in London to help strengthen the UK arm of our businesses and showcase products such as Oralieve® Dry Mouth Relief. We pride ourselves on delivering an ethical and professional service to a broad spectrum of customers including suppliers, healthcare professionals and end users and hope to meet new contacts at the exhibition.”

CHAPPER healthcare exports to over 65 countries across the globe. They offer a wide range of high-quality products including branded and generic pharmaceuticals, orphan drugs, over the counter medicines, veterinary medicines and other medical supplies.

The Clinical Pharmacy Congress is taking place from 7th-8th June 2019 at ExCeL London and is the largest gathering of clinical pharmacy professionals in Europe – bringing together thousands of clinical pharmacy professionals to enhance their learning and networking opportunities.

For more information or to book an appointment with the CHAPPER healthcare team, please contact: UKenquiries@chapperhealthcare.com or visit www.chapperhealthcare.com

About CHAPPER Healthcare
Formerly Philip Chapper & Company Limited, CHAPPER healthcare is a world class medical supplies wholesaler and distributor, specialising in importing and exporting pharmaceuticals and medical supplies to markets across the globe. Established in 1975, the company are experts at sourcing products, consolidating orders and organising shipments to any destination. Their customers include government ministries, hospitals, clinics, pharmacy chains, health professionals and medical distributors. For more information please visit www.chapperhealthcare.com

Two state-of-art 3D mammography systems that offer women a more comfortable breast exam experience have been installed at the University Hospitals of Derby and Burton NHS Foundation Trust.

The technology – GE Senographe Pristina Mammography System – was installed by Althea as part of the Trust’s Managed Equipment Service (MES) contract.

The upgraded facilities include a tomosynthesis, biopsy and contrast enhancement – features that the hospital’s old equipment didn’t have. The extra additions enable the Royal Derby team at UHDB’s Royal Derby Hospital site to be at the forefront of technology and research enabling the people of Derby to get the best diagnostic care.

The Senographe Pristina mammography system was designed to ease anxiety of patients as they enter the exam room. The new, inviting mammography promotes a sense of calm and has redesigned patient comfort to ensure women are comfortable during their examination.

Having these capabilities on both pieces of equipment enables patients in Derby to have multiple elements of care in one visit, rather than having to come back for the biopsy on a separate occasion. Clinicians also benefit from these installations as they increase the Trust’s scope of practice and meet requirements for continued professional development.

Lee Chlechowicz, Breast Screening and PACS Clinical Manager, added: “The new pieces of equipment are ergonomically designed and has enhanced capabilities which enables our patients to have a more comfortable and comprehensive diagnostic experience in a single visit, rather than having to come back for the biopsy on a separate occasion. Our clinicians and radiographers also benefit from these installations as they increase our scope of practice and meet requirements for continued professional development.”

Althea is the world’s largest, vendor-independent managed service and maintenance provider for the acute healthcare sector.

The medical technology service company offer UK and Ireland hospitals a range of technology services including multi-vendor maintenance, integrated clinical consumables management and equipment sales/rentals.

Althea has a 10-year contract with the Trust which started in 2014.

About Althea
With close to 3,000 staff worldwide, Althea is now the largest independent provider of medical equipment services with 1.4 million medical devices under management in more than 1,700 healthcare facilities. Althea focuses on its breadth and quality of service, freeing its customers to focus on patient care.

Citizens Medical Center (Citizens) entered into an agreement with Enchanted Rock, LLC (Enchanted Rock) to make sure power outages no longer impact the safety, medical care, and comfort of its patients. Enchanted Rock’s natural gas microgrids will supply redundant electrical service for Citizens, ensuring the hospital will maintain full power despite natural disasters or other utility interruptions.

When Hurricane Harvey swept through the Gulf Coast in August 2017, Citizens experienced the immediate impacts of power failure. The hospital was equipped with an emergency generator, but like most hospitals, it only had the capacity to support the equipment, life safety and critical loads required for regulatory compliance. Backing up only the required loads, but not the entire facility, can lead to patient risk and operational disruption. During Harvey, the loss of both electricity and water at Citizens was risky enough to require patients to be evacuated to a safer location.

“After our experience during Harvey, we wanted to find a way to remain open and be the safe location the community needs next time a disaster strikes,” said Citizens CEO, Mike Olson. “We now feel confident going into the 2020 hurricane season knowing that our power resiliency is in the hands of experts and were surprised to discover that this risk could be addressed so affordably with Enchanted Rock’s proven resiliency solution.”

Citizens selected Enchanted Rock, a Houston-based company that offers resiliency as a service. Enchanted Rock’s natural gas backup generators have a track record of providing continuous electrical service during severe weather events, including Hurricane Harvey, which made the company an attractive choice to Citizens. Unlike other alternatives, Enchanted Rock’s microgrids provide full facility backup. Their natural-gas powered engines can run indefinitely with unlimited fuel supply delivered through robust underground infrastructure. The hospital will now be able to remain open and serve the community even when the utility service goes down.

In addition to being the most resilient choice, Citizens also selected Enchanted Rock generators for their attractive financial terms. The company’s unique Integrated Reliability on Call (iROC) service allows Citizens to pay a small fraction of the total cost of owning a standard reliability system, making Enchanted Rock the most cost-effective choice for the hospital.

“During disasters, hospitals shouldn’t be closing to evacuate patients,” said Thomas McAndrew CEO of Enchanted Rock. “They should be open to serve the community and save lives and we are delighted to be able to help Citizens achieve this goal.”

Texas Microgrid, LLC owns, and Enchanted Rock operates the system for the life of the agreement, allowing Citizens to focus their time and energy on what matters most – providing high-quality service for their patients. Citizens anticipates this solution will be constructed and ready for operation just in time for the 2020 hurricane season.

About Citizens Medical Center

Citizens Medical Center is a not-for-profit hospital known for compassionate patient care, clinical expertise, and bringing advanced medical services to the South Texas region since 1956. Today, Citizens is a 338-bed acute care hospital with over 1,000 employees. Citizens Medical Center is recognized for its outstanding cardiology program, which includes a nationally accredited Chest Pain Center. Citizens has a Comprehensive, Accredited Bariatric Surgery program, a nationally accredited Comprehensive Community Cancer Program by the American College of Surgeons Commission on Cancer and has a 24/7 emergency department, advanced Level III Trauma facility and onsite medical helicopter, a Primary Stroke Center, imaging and surgery center, sleep study center, Citizens Birth Center with labor and delivery, state-of-the art rehabilitation and fitness center, urology center and DaVinci robotics minimally invasive surgery options, a home health agency, and has a long history of providing continuing education for healthcare providers and the community.

About Enchanted Rock

Enchanted Rock has pioneered a service offering that enables commercial, industrial and institutional customers to achieve much higher levels of facility electrical reliability for a small fraction of the cost of traditional diesel backup generation ownership. They are the only distributed energy company combining expertise in energy market integration, control technologies, and construction which translates into more reliable and less expensive backup power for customers. Enchanted Rock is responsible for the design, project management, installation, and commissioning of 360 MW of distributed generation with over 60 MW under construction. To learn more, visit www.EnchantedRock.com.

GE Healthcare and Medhold have announced the launch of CARESCAPE ONE in South Africa. The announcement was made during the Africa Health 2019 themed The future of healthcare today: Re-envisioning Africa’s healthcare system.

Today’s intra-hospital patient transport has become an important part of healthcare delivery. It is a complex and highly sensitive process that requires adherence to high quality and safety standards. It is also a time-consuming task for nurses working in critical care areas, often resulting in nurses performing various tasks with higher physical and psychological requirements. The process can be stressful for both the patient and the nurse in charge of the transfer especially in emergency room, the operating room, and the intensive care unit where patients need very close surveillance and doctors need real-time information on the patient’s vital signs.

CARESCAPE ONE is an advanced lightweight plug-and-play monitoring solution for conducting intra-hospital patient transport. It allows nurses to visually monitor critical patient conditions with precision during active patient transport between care areas. The solution is a portable monitor device with docking capability on the transport bed or at the bedside. It is designed to provide an efficient workflow with the added benefit of relative ease of use for new as well as experienced users. The system also provides a standardized yet fully flexible platform with one device and one software to support cost effective fleet management.

A unique feature that contributes to the ease of use and flexibility of application across the healthcare institute is the CARESCAPE parameter concept. Using CARESCAPE ONE with CARESCAPE parameters appropriate to the patient means that only one standard CARECAPE ONE device is required and the parameter set is tailored by simply connecting the required parameters. This flexibility extends to the ability to use different pulse oximetry technologies in different care areas to provide the optimum monitoring solution and patient care. As a result, healthcare facilities benefit from optimized device inventory and reduced caregiver stress caused by the correctly configured device not always being available.

“Our mission at GE Healthcare is to save lives in moments that matter – CARESCAPE ONE is a good demonstration of this mission. We are proud to partner with Medhold to make a lasting impact in intra-hospital transport across South Africa’s healthcare facilities,” said Graham Maritz, General Manager GE Healthcare Southern Africa.

Both qualitative and quantitative results from a recent comparative usability study conducted to assess the workflow impact and evaluate productivity gains during active patient transport using the CARESCAPE ONE as compared with a patient transport monitor of similar class showed that CARESCAPE ONE can help improve patient transport safety and staff efficiency. Specifically, the study found that participants using the CARECAPE ONE monitor experienced overall 26% less patient transport time, and 60% fewer user errors in performing routine transport tasks.

Africa Vision 2030, General Country Health Policies, Universal Health Coverage (UHC) in the Sustainable Development Goals and Innovations & Changes in Cancer Therapy are just some of the key issues to be addressed at the AHES 2019.

The 2nd Edition Africa Healthcare Extension Summit (AHES) is going to take place on 26 – 27 June 2019 at The Panari Hotel, Nairobi, Kenya. Under the patronage and supervision of Ministries of Health Zambia, Malawi, Lesotho and Zimbabwe, the two-day summit aims to revolutionize the Africa’s healthcare sector.

AHES 2019 is being supported by Africa Healthcare Federation, East Africa Healthcare Federation, Kenya Healthcare Federation, Federation of African Medical Student’s Association, Africa Mental Health Foundation Kenya, Kenya Medical Association and Midlands State University. The event also garnered support from Varian, the Medical Device Industry Partner.

More than 30 speakers with a range of expertise and perspectives have been lined up to take part including Ministers of Health from across the Africa such as Hon. Minister Chitalu Chilufya (Zambia), NkakuKabi (Lesotho), Dr. Dan Namarika (Zimbabwe), Simon Berry (Co-Founder and CEO, ColaLife) who will talk about the Role of Innovation in augmenting Healthcare.

“I will be highlighting the key success factors in our journey from an innovative idea to a self-sustaining development that has transformed access to diarrhea treatment in Zambia. This will include our partnership with the Zambia Ministry of Health and the way we worked with Community Health Workers. I will be there for the whole conference and look forward to engaging with fellow delegates”, Simon Berry from ColaLife said.

To register at the summit, visit www.ahesummit.com/ register or email info@ahesummit.com

Verve Management is UAE’s business facilitating platform that connects people, partners and ideas. Verve Management delivers remarkable events and provide solutions through Congresses & Summits, Trainings & Workshops, Exhibitions, Association Management, Industry Meetings and Managed Events in Asia, Middle East and Africa. For more information on Verve Management, kindly visit – http://www.verve-management.com/

ISSUED BY
Verve Management UAE
2501, HDS Tower, Cluster F, Jumeirah Lakes Towers
Dubai, UAE
Mobile: +971 4 243 4677/88
Email: info@ahesummit.com

In recent years, with the improvement of China’s national income, the rapid increase of the middle class and the increasing demand for overseas medical care, many overseas medical groups regard China as an important strategic area for future development.

At the same time, under the encouragement and promotion of China’s policies. More and more foreign-funded hospitals are building highend medical institutions in China. The expansion of the high-end medical market has placed new demands on high-end medical services.

The “Top Healthcare Congress China 2019” will be held on June 27th and 28th, 2019 in Shanghai, China. It will gather relevant government officials, local health bureau, high-end medical groups, high-end general hospitals and clinics, high-end specialized hospital and clinics, high-end services departments from public hospitals, medical property developers, and outstanding solutions providers, etc. to discuss on intelligent means, latest technologies, and operational challenges to explore the present situation and future development of Chinese high-end healthcare market, so as to find the best partners.

Hot Topics

• Latest Development Report of China High-end Healthcare Industry
• Research on Application of Medical Certification in High-end Medical Treatment
• How to Plan the Design of High-end Medical Facilities in China
• Focusing on Green Hospital Construction, Creating Modern Healthcare Environment with High Standards
• High-end Hospital Building Energy Conservation and Energy Efficiency Management
• Discussion on Planning and Operation Management of Hospital Medical Equipment Configuration
• On Clinical Spatial Planning of High-end Hospitals in China
• Quality Logistics Management and Innovation Mode Sharing in High-end Hospitals
• How to Implement Medical Resource Sharing Model Through “Medical Mall”
• How Informatization Solution Boosts High-end Hospital Construction

Exclusive Formats

• ORGANIZER- HOSTED ACTIVITIES: Receive invitations to special activities organized for our conference.
• ONE-TO-ONE PRESCHEDULED BUSINESS MEETINGS: Promote and sell services and products directly to the true decision makers and power players who are searching for your industry solutions for their current and upcoming projects.
• ORGANIZED DINNER: Be part of a uniquely designed dinner with top-level representatives from the industry.
• LIMITED SPEAKING SLOTS: Demonstrate your expertise to your prospects via a tailored speech.
• EXHIBITION BOOTHS: Showcase your product profile and stimulate interaction with delegates at your booth in the networking area.
• SITE TOUR: Exclusive tours will be offered enabling you to maximize the value of your time at the summit.

About Noppen
Noppen Group is a leading international company facilitating business across Asia, Europe, Africa and Latin America. Driven by the desire for excellence and supported by an unparalleled understanding of the Asian, European, African and Latin American markets, Noppen Group has delivered exceptional events, assisted new market entries and established government relations since 1998. Our top-level business connections paired with our close relations to the many levels of government have given Noppen an edge on the marketplace our competitors just cannot match. With offices in China, Belgium, India, Philippines and Colombia; Noppen Group offers reputable, reliable services and a large range of deliverables to help your company successfully meet its goals.